These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19695357)

  • 1. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary intervention/ stenting.
    Lip GY; Huber K; Andreotti F; Arnesen H; Airaksinen KJ; Cuisset T; Kirchhof P; Marín F;
    Thromb Haemost; 2010 Jan; 103(1):13-28. PubMed ID: 20062939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
    Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
    EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensity of antiplatelet therapy in patients with acute coronary syndromes and percutaneous coronary intervention: the promise of prasugrel?
    Wiviott SD
    Cardiol Clin; 2008 Nov; 26(4):629-37. PubMed ID: 18929236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to minimize bleeding complications of percutaneous coronary intervention.
    White HD
    Curr Opin Cardiol; 2009 Jul; 24(4):273-8. PubMed ID: 19474710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 9. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 10. Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Willis P; Voeltz MD
    Am J Cardiol; 2009 Sep; 104(5 Suppl):34C-8C. PubMed ID: 19695359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 13. The relationship between bleeding and adverse outcomes in ACS and PCI: pharmacologic and nonpharmacologic modification of risk.
    Manoukian SV
    J Invasive Cardiol; 2010 Mar; 22(3):132-41. PubMed ID: 20197582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet agents in acute coronary syndromes.
    Sakhuja R; Yeh RW; Bhatt DL
    Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.
    Bryniarski L; Pelc-Nowicka A; Zabojszcz M; Mirek-Bryniarska E
    Cardiol J; 2009; 16(2):179-89. PubMed ID: 19387970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary angioplasty in acute coronary syndromes: adjuvant drug therapy and management of the bleeding risk due to antithrombotic agents].
    Zagnoni S; Casella G; Musuraca AC; Calabrese D; Pavesi PC; Di Pasquale G
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):34S-42S. PubMed ID: 21491738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications and management of bleeding events in patients with acute coronary syndromes.
    De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored antithrombotic therapy for acute coronary syndromes.
    Fitchett D
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):935-44. PubMed ID: 18666844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tug of war.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):1C-3C. PubMed ID: 19695353
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy for improving post-PCI outcomes: interpreting current treatment guidelines for optimal management of the post-ACS patient.
    Cross J
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S48-53. PubMed ID: 19355809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.